Here's the recent articles submitted by dengyue medicine
Articles By dengyue medicine
Advancements In Oncology: China's Emerging Leadership In Innovative Cancer Therapies
Submitted as: dengyue
China's 2025 NRDL adds 114 drugs & first commercial insurance list covers CAR-T therapies, boosting oncology access. DengYueMed views this as key to innovation & affordability in precision cancer care.(read
entire article)
View : 113 Times
Category : Health
Biosimilars Are Here! How Should Patients Choose Between Originator Biologics And Biosimilars?
Submitted as: DengYueMed
Learn the key differences between originator biologics and biosimilars, including safety, efficacy, costs, common uses, and how patients can choose the right treatment.(read
entire article)
View : 22 Times
Category : Health

